Scientists have bioengineered Spirulina to produce active vitamin B12, previously found only in animal products, offering a ...

The way we produce and consume food is changing. Not only is the current food system a threat to our health, it’s also a ...

IF FUTURE FOOD is fun, entertaining, and fantastic, it is also deeply embedded in culture, science, AI and state-of-the-art ...

Hematologist-oncologist Mateo Mejia Saldarriaga, MD, combines clinical care with research aimed at helping patients with ...

Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive ...

According to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an initial public offering (IPO) on the week of April 7th, IPO Scoop reports. The company plans to issue 2,700,000 shares at $7.

WELLESLEY HILLS, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced the appointments of ...

Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug ...

Introduced by the Times Now Global Sustainability Alliance (GSA), this inaugural summit will bring together industry leaders, policymakers, innovators, and sustainability champions to shape the future ...

Emrosi™ approved by FDA for the treatment of inflammatory lesions of rosacea in adults, with commercial launch underway; initial distribution ...

Biotech stocks plunge after Dr. Peter Marks resigns from FDA, citing disputes with RFK Jr. over vaccines and drug approvals.